Navigation Links
JRC develops new testing methods for contaminated sports drinks from Taiwan
Date:7/29/2011

Brussels, 29 July 2011 - The European Commission's Joint Research Centre has developed three new methods to detect an illegal clouding agent which can be found in sports drinks imported from Taiwan.

In late May, the Taiwanese authorities informed the European Commission that significant amounts of phthalates were illegally added to certain categories of sports drinks. These chemicals are believed to affect reproductive performance and fertility, and have been linked to developmental problems with children.

Under a request from the Commission's Directorate-General for Health and Consumers, the JRC developed and validated three new testing methods that allow the substance to be rapidly and accurately detected. The methods are freely available on the JRC website and are intended to facilitate the work of laboratories in the EU and world-wide involved in the testing of suspected products. Testing laboratories are invited to submit their feedback regarding the performance of the methods to the JRC, which will analyse the findings and improve the methods, if necessary.

The Taiwanese Food and Drug Administration has published the names of 879 products of more than 300 producers that contained high amounts of phthalates. More than 200 products from 34 producers were exported to 22 countries. These include some EU Member States, in particular Germany and the UK, where some products were withdrawn from the market.

What are phthalates?

Normally, producers of sports drinks, jelly and fruit pulps use a palm-oil based product to obtain a cloudy appearance, but in the Taiwanese incident, this was largely replaced by the two cheaper substances: bis-(2-ethylhexyl) phthalate (commonly abbreviated DEHP), and - in one case - di-iso-nonyl phthalate (DINP). DEHP and DINP are commonly used as plasticizers in many plastic products. These substances, however, are prohibited in the production of food, and their use in plastic toys and childcare products is restricted in the EU.


'/>"/>

Contact: Francesca Micheletti
francesca.micheletti@ext.ec.europa.eu
European Commission Joint Research Centre
Source:Eurekalert

Related medicine news :

1. Carnegie Mellon develops iPhone app that predicts when bus will arrive
2. University of Leicester develops test for classifying force used in bottle stabbings
3. UT Southwestern pediatric urologist develops procedure to eliminate scarring in kidney surgeries
4. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
5. New grant to study how pediatric brain tumor, ependymoma, develops
6. CHEO Research Institute develops secure protocol for data disclosure
7. Queens develops new brain training app for research into aging minds
8. 1 in 5 Kids With Cold Develops Middle Ear Infection: Study
9. Mount Sinai develops first screening tool for war veterans to assess traumatic brain injury
10. Study reveals major shift in how eczema develops
11. Tecnalia develops environment-friendly and health-friendly pest control products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Los Angeles, CA (PRWEB) , ... February 28, 2017 , ... ... prostate cancer and vasectomies. In studying approximately 800 deaths from prostate cancer, the researchers ... prostate cancer and 20% more likely to get fatal prostate cancer. Although the increased ...
(Date:2/28/2017)... ... February 28, 2017 , ... TruClinic Inc. ... intelligence company based in New York. , “Ensuring an intuitive, user-friendly patient experience ... unaltered. Those two fundamental reasons are the reasons this acquisition is an obvious ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... 2017, from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville ... compliance, performance analytics, and engagement strategies. , The discussion will include best practices ...
(Date:2/27/2017)... ... February 27, 2017 , ... Hotze Health ... announces Chris Brandl as its New Guest Director. , Brandl is a ... throughout his career. He began his professional career at Omnium Worldwide, now known ...
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... -- Halyard Health, Inc. (NYSE: HYH ) today ... 2017 outlook and related key planning assumptions. Executive Summary ... 2 percent increase compared to the prior year. ... million compared to net income of $15 million in the ... $24 million compared to adjusted net income of $27 million ...
(Date:2/27/2017)... , Feb. 27, 2017 Mederi Therapeutics ... 28 studies, representing 2468 patients who received  Stretta ... study entitled, " Systematic Review and Meta-Analysis of ... Radiofrequency for Treatment of Gastroesophageal Reflux Disease ", was ... Ronnie Fass , MD, head of the ...
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
Breaking Medicine Technology: